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ABSTRACT
Retroviral and lentiviral vectors integrate their DNA
into the host cell genome leading to stable trans-
gene expression. Integration preferentially occurs in
the proximity of active genes, and may in some case
disturb their activity, with adverse toxic conse-
quences. To efficiently analyze high numbers of
lentiviral insertion sites in the DNA of transduced
cells, we developed an improved high-throughput
method called vector integration tag analysis (VITA).
VITA is based on the identification of Genomic Tags
associated to the insertion sites, which are used
as signatures of the integration events. We use
the capacity of MmeI to cleave DNA at a defined
distance of its recognition site, in order to generate
21 bp long tags from libraries of junction fragments
between vector and cellular DNA. The length of the
tags is sufficient in most cases, to identify without
ambiguity an unique position in the human genome.
Concatenation, cloning and sequencing of the tags
allow to obtain information about 20–25 insertion
sites in a single sequencing reaction. As a validation
of this method, we have characterized 1349 different
lentiviral vector insertion sites in transduced HeLa
cells, from only 487 sequencing reactions, with
a background of ,2% false positive tags.
INTRODUCTION
Retroviral elements integrate DNA copies of their genome
into the host cell chromosome. This property has allowed
them to spread into the genome of vertebrates and contribute
to their evolution (1). It is also exploited in retrovirus-derived
vectors that are commonly used for stable gene transfer
in experimental and therapeutic settings. Successful gene
therapy treatments using retroviral vectors have also revealed
the genotoxicity of retroviral integration and called for a
better understanding of the integration process (2,3). Retrovi-
ral DNA integration is mostly independent of the sequence
context and has long been considered to occur at random
locations in the host cell genome (4). Recently however, it
has become possible to perform genome-wide analysis of
retroviral integration events, and these ‘integrome’ studies
have revealed strong biases in the distribution of integration
sites (5). Lentiviruses (HIV-1 and SIV-1), MLV and ASLV,
as well as gene transfer vectors derived from them, all
display a more or less pronounced preference for transcrip-
tion units (6,7). Different integration behaviours have been
demonstrated among retroviruses, with lentiviruses integrat-
ing their proviral DNA all along the transcription units,
while MLV (a gammaretrovirus) display a marked preference
for the proximal region of active genes (8), ASLV shows only
a weak tropism for transcription units without any prefer-
ence for the integration position. Integrome proﬁles are also
dependent on the host cell origin and physiological state
(7,9). Further biases with other genomic features may
exist and could be discovered through larger integrome
analysis.
Yet, these studies require the characterization of hundreds
of integration sites in order to be informative. Today the most
popular technique is linear ampliﬁcation mediated PCR
(LAM-PCR) (10) which is derived from linker mediated
PCR (LM-PCR) and involves the isolation and sequencing
of individual junction sequences between proviral and
host genomic DNA. Our goal here was to increase the
throughput of current integration site analysis by allowing
for the simultaneous analysis of multiple sites in a single
sequencing reaction. We describe a method called vector
integration tag analysis (VITA), based on the identiﬁcation
of genomic tags (11) close to the insertion sites which can
be used as a signature of the integration event. As in the
long-SAGE technique (12), we use the capacity of the
tagging MmeI enzyme to cleave DNA at a deﬁned distance
of its recognition site, in order to generate 21 and 22 bp
long tags. This length is sufﬁcient, in most cases, to identify
without ambiguity a unique position in the human genome.
Concatenation, cloning and sequencing of tags allow
to obtain information about 20–25 insertion sites in a single
sequencing reaction.
We report the characterization using VITA, of a population
of integration sites in the genome of human cells transduced
with a lentiviral vector. We show that the method accurately
and efﬁciently describes the integrome and its association
with gene-enriched regions of the genome.
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Cells
Cells from HT1080, a human ﬁbrosarcoma cell line, were
transduced with a VSV-G pseudotyped Self-Inactivated
lentiviral vector containing a GFP gene (pRRLSINc-
PPT_PGKGFP_WPRE) at a multiplicity of infection (MOI)
of 1. A clone (HT3) was isolated by limiting dilutions and
cell sorting on the basis of GFP expression level, using
a MoFlo cell sorter. HeLa cells were transduced twice with
the same HIV-1 based vector (1.10
10 TU/ml) at a MOI of
5, and were harvested after an average of 28 doublings.
A subpopulation representing 25% of the cells was isolated
on the basis of its high GFP expression levels.
Insertion site fragments (ISF) library
Five microgram of puriﬁed DNA from transduced cells were
digested with 10 U of NlaIII (Biolabs).
The NlaIII compatible adaptor (OL) was obtained with two
synthetic oligonucleotides (OLS and OLL, Table 1) which
were mixed, heated at 95 C for 10 min and cooled slowly
to room temperature. A 5-fold molar excess of this adaptor
(0.45 mg) was ligated with 100 ng of NlaIII digested DNA
using 1 U of T4 DNA ligase (Invitrogen) in a 20 ml reaction
volume. A ﬁrst linear ampliﬁcation of integration sites was
done with 10 ml of this ligation and 1 pmol of biotinylated
oligonucleotide (bOC) (Table 1) (six cycles: 30 s, 92 C;
30 s, 58 C; 1 min 30, 72 C) in 5 mM MgCl2, 200 nM
dNTPs, and 1 U of Platinum  Taq DNA polymerase in
its buffer (Invitrogen). This ampliﬁcation provided biotin-
labelled DNA fragments starting in the vector and ﬁnishing
at the ﬁrst NlaIII restriction site in the host genome beyond
the vector 50 end. Streptavidin-coated paramagnetic beads
(0.5 mg Dynal Biotech) were washed in 50 mlo f5m M
Tris–HCl pH7.5, 0.5 mM EDTA, 1 mM NaCl and mixed
with DNA fragments for 20 min at room temperature. DNA
attached to the beads was ampliﬁed by 15 cycles of PCR:
15 s, 92 C; 30 s, 59 C; 1 min 30, 72 C. 1 U Platinum 
Taq DNA polymerase, 5mM MgCl2, 200 nM dNTPs,
25 mmol of both PVE and PLE (Table 1). PCR products
were diluted 1000-fold and submitted to a second ampliﬁca-
tion (30 cycles) using a nested set of primers (PVI and
PLI, Table 1) under the same conditions except for a
reduced annealing temperature (56 C). Products of this
PCR constitute the ISF library. An aliquot was cloned into
pCR 2.1-TOPO (Invitrogen).
Tags extraction
After ethanol precipitation, the ISF library was digested with
4 U of the tagging enzyme (MmeI, 1 h at 37 C). This resulted
in the release of the adaptor with the adjacent genomic DNA
(59 bp fragment) which was puriﬁed through a 12% polyacry-
lamide gel (Spin-X , Costar ). Puriﬁed DNA was linked to
a second adaptor, LN, adding a new NlaIII site and a TT
dinucleotide that introduces an asymmetry for orientation
purposes. LN degenerate adaptor was prepared by annealing
two synthetic oligonucleotides (LNL and LNS, see Table 1)
as described above for OL. Ligation products were diluted
200-fold and used in 200 individual PCR under the following
conditions; 92 C, 30 s; 58 C, 30 s; 72 C, 1 min 30 s;
30 cycles, 50 ml reaction in 5 mM MgCl2, 200 nM dNTPs,
500 nM biotinylated primers bPLN and bPLI (Table 1) and
1 U of Platinum  Taq DNA polymerase with its buffer.
PCR products were pooled and ethanol precipitated. The
resulting 97 bp DNA fragment was puriﬁed through a 12%
polyacrylamide gel and digested with 2 · 100 U of NlaIII
in a 400 ml-reaction (2 · 1 h at 37 C). After digestion,
tags were puriﬁed away from biotinylated fragments using
streptavidin coated magnetic beads. Unbound tags were
recovered in the supernatant and precipitated before puriﬁca-
tion on a 12% polyacrylamide gel. The puriﬁed tags were
then concatenated using 5 U of T4 DNA ligase in 10 mla s
recommended by the supplier, for 3 h at 16 C. Concatemers
(600–1000 bp long) were puriﬁed on a 1.5% agarose gel (Kit
Qiaquick, Qiagen) and cloned into SphI-site of a pZero-1
plasmid (Invitrogen). Recombinant clones obtained after
electroporation of TOP10 cells (Invitrogen) were selected
on LB-low salt plates containing 50 mg/ml zeocin.
Sequencing and analysis
Sequencing reactions were performed using Big Dye termina-
tor sequencing chemistry (Applied Biosystems) from the
M13 forward or M13 reverse primers and run on a 377-XL
Applied Biosystems automated sequencer. Sequences
obtained from the ISF were matched on the human genome
using the BLAT program (UCSC Human Genome Working
Draft, May 2004 freeze). A sequence was considered to be
a ‘bona ﬁde’ vector-genome junction if: (i) it contains the
sequence of the 50 end of the vector and those of the adaptor
OL; (ii) it matches with one genomic locus showing >95%
identity. Integration was considered to have occurred in
gene only if it was located within the boundaries of one of
the RefSeq genes (UCSC Genome Browser on Human May
2004 Assembly).
Table 1. Oligonucleotides used in VITA protocol
Oligo Sequence Description
bOC b-AAAAAAAAAATACTGA-
CGCTCTCGCACCCATCTCT
Position 383–407 on
HIV genome, linear
amplification of junctions
PVE TCTCGCACCCATCTCTCTCC Position 379–398 on
HIV genome, amplification
of junctions fragments
PVI TGGTTTCCCTTTCGCTTTCA Position 255–274 on
HIV genome, amplification
of junctions fragments
OLS TCGGAGAAGAGGATACGGA-
TTGTAGGCAGGGGGACGCCT-
CAAGAATAAGGGCT-a
OLL CCCTTATTCTTGAGGCGTCC-
CCCTGCCTACAATCCGTATC-
CTCTTCTCCGACATG
PLE CCTTATTCTTGAGGCGTCCC
PLI GGCGTCCCCCTGCCTACAAT
bPLN b-CGACGAGACACTGCCCCTGA
bPLI b-GTCCCCCTGCCTACAATCCG
LNS AACATGTTTGAATCTGTTTCA-
GGGGCAGTGTCTCGTCGGGA-a
LNL GAGTCCCGACGAGACACTGCC-
CCTGAAACAGATTCAAACAT-
GTTNN
b ¼ biotin, a ¼ amine.
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made software (available upon request) that performs the
following steps; (i) Locate the NlaIII sites (CATG) within
the tags concatemers; (ii) Extract tags of length 21–30 bp
which fall between these sites and orientate them (two
consecutive T are used to orientate the adjacent tags). (iii)
Exclude ambiguous tags (Tags with Ns, tags unable to be
orientated) (iv) Count number of occurrences of each tag;
(v) Remove repeated occurrences of tags.
The result of this process is a fastA ﬁle of tags which can
be used as an entry to a similarity search of the genome
(Goldenpath). The Blast software was used to map tags on
the human genome with parameters which force perfect
alignments ( W ¼ 21;  e ¼ 0.1). To test whether the
number of integrations was correlated to the number of
genes per chromosome, we used the Pearson’s correlation
test which measures the strength of the linear relationship
between two variables.
RESULTS
VITA overview
Twenty-one nucleotide long tags are enough to unambigu-
ously deﬁne a genomic site in 70% of cases. The method
described here is designed to extract and analyze such short
sequences in the vicinity of retroviral integration sites. It is
based in the ability of the MmeI restriction enzyme to cut
DNA outside of its recognition site and includes two steps:
the production of an ISF library and the extraction of a
21 bp tag from each fragment. Figure 1 gives a general
outline of the method and the different oligonucleotides
used are listed in Table 1.
ISF library. The genomic DNA from cells transduced with a
lentiviral vector was digested with a high frequency cutting
restriction enzyme [NlaIII (CATG), anchoring enzyme].
Restriction fragments were then ligated with a NlaIII
compatible adaptor which contains a MmeI restriction site
(OL, see Table 1). OL oligonucleotides were not phosphory-
lated, resulting in a ligation reaction in which only their
30 protruding end was covalently bound to genomic DNA.
A linear ampliﬁcation of insertion site fragments contain-
ing vector-genomic DNA junctions was then performed
using a bOC (Table 1) that hybridizes with the vector
sequence outside of the LTRs. In this reaction, the OL
adaptor and its MmeI site were replicated at the end of
the ISFs which were then puriﬁed with paramagnetic
streptavidin-coated beads.
ISFs were then ampliﬁed by nested PCR with primer in
the vector (PVE/PLE, Table 1) and in the OL adaptor (PVI/
PLI, Table 1). This step was necessary, because it eliminated
unwanted NlaIII fragments carrying the OL adaptor which
could contaminate the ISF, but did not contain vector
sequences.
Tag extraction. The ISFs library was digested by MmeI,
yielding 21–22 bp DNA tags linked to the OL sequences.
MmeI produces a 2 nt 30 protruding end that cannot be ﬁlled
by DNA polymerase. In order to preserve the information
from this end, the MmeI products were ligated to an
adaptor oligonucleotide with a random 2 nt 30 protruding
end (LN, Table 1).The LN adaptor also contains a NlaIII
site for tag concatemer formation (see below). A TT
dinucleotide was added at the 30 end of LN. This ‘tag in
the tag’ introduces an asymmetry that permits to orientate
the tags. Ligation products were PCR ampliﬁed using two
biotinylated primers hybridizing to OL and LN (bPLN/
bPLI, Table 1) and cleaved by NlaIII. Biotinylated fragments
were then eliminated with streptavidin-coated beads, 21 bp
tags with NlaIII remaining in solution were gel-puriﬁed,
ligated into concatemers and cloned in a bacterial plasmid.
Complex integrome analysis
In order to validate the VITA method, we analyzed the
integration sites in a HeLa cell population transduced with
a lentiviral vector (pRRLSINcPPT_PGKGFP_WPRE) (13)
at a MOI of 5.
HeLa ISF library. An ISF library was obtained as described
above and introduced into pCR 2.1-TOPO plasmid. 82 clones
were sequenced in order to analyze the redundancy of the ISF
population. Seventy-ﬁve clones had the expected structure,
including 274 bp from the provirus, a variable length of
genomic DNA and the OL adaptor sequence next to a NlaIII
site. Of those, 66 (91%) were long enough to be analyzed by
BLAT (14), 8 were in repeated regions and 58 could be
assigned to a speciﬁc genomic site, identifying 54 different
integration sites.
Figure 1. Overview of VITA method. All steps are detailed in ‘Materiel and
Methods’. For oligonucleotides information, see Table 1.
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cloning, we performed 487 sequencing reactions that yielded
7831 tags after extraction using a home-made software.
Non-oriented tags starting with AA and ﬁnishing with TT
were excluded from the analysis. 6872 tags had the expected
size, did not contain sequence ambiguities and could be
precisely oriented using the TT dinucleotide on the LN
adaptor. Tags redundancy is shown in Figure 2.
A total of 2480 different tags were obtained and mapped on
the human goldenpath (hg17) by using BLAST with parame-
ters that force perfect alignment ( W ¼ 21,  e ¼ 0.1).
Among these tags, 1349 were localized at unique positions
and designated ‘one hit’. Tags without match on the genome
(n ¼ 632) were called ‘no hit’ and tags with multiple hits
(n ¼ 499) were called ‘multi hit’.
In order to estimate the complexity of the tag population
we represented the number of different tag in each category
(‘one hit’, ‘no hit’, ‘multi hit’) as a function of the cumulated
number of sequenced nucleotides (Figure 3). All the curves
are far from the asymptote, indicating that the tag population
can still be extensively exploited.
Examination of the ‘no hit’ population indicated that 20%
of them (132/632) contained sequences of proviral origin, due
to insertions very close to a NlaIII site on the genome. The
remaining ‘no hit’ tags could originate from insertions into
non sequenced parts of genome, but most are probably
mutant versions of real tags, that appeared during one of
three PCR included in the protocol. Reciprocally, this raised
the possibility that certain tags with hits in the genome could
also be the result of error-prone PCR. In order to estimate the
probability of wrongly identifying insertion sites, we selected
a population of 303 ‘bona ﬁde’ 21 bp tags deduced from
sequenced ISF clones and created a virtual population of
 50 000 mutated tags, by changing one position in each of
them (base change, deletion or insertion). None of the virtual
tags could be matched on the genome and therefore would
not lead to erroneous insertion site identiﬁcation.
Integrome analysis in a cell clone
The accuracy of the VITA method as well as the possibility to
generate ‘false tags’ were further tested on a cellular clone
containing a known set of integrated proviral genomes. The
HT3 clone was obtained after transduction of HeLa cells
as described above (see Materials and Methods), and the
number of integration sites was determined to be at least
seven by Southern blot analysis (data not shown).
HT3 ISF library. An ISF library was obtained from the HT3
clone DNA, as described above. We sequenced 83 clones,
and 82 of them were found to represent actual junctions
between vector and genomic DNA. These junctions corre-
sponded to eight different integration sites. Each integration
event was sequenced 4–13 times (average: 10.25, median:
11.5), which suggested that we had saturated our junctions
library analysis and that integration sites had been identiﬁed.
One of sequenced clones did not have the expected vector-
genome DNA structure. A tag library was then constructed
and analyzed, in order to evaluate the number of false
positive generated by the method.
HT3 tag library. We obtained 913 tags by sequencing 70
concatemer clones. Of those 266 corresponded to one of the
eight expected insertion sites. Among the remaining tags, 533
could be oriented and were analyzed by BLAST, 517 were
‘no hits’, 8 were ‘one-hit’ and 8 were ‘multi-hit’. The origin
of ‘no-hit’ tags was further investigated. The 517 ‘no-hit’ tags
were compared with the nine expected tags from the nine
ISF library clones (eight true tags and one contaminant).
A total of 508 out of 517 ‘no hit’ tags were very similar to
one of the nine expected tags suggesting that the principal
source of ‘no-hit’ tags were PCR associated mutations.
These 517 ‘no hit’ would be discarded in a standard analysis
(see above) and therefore, we estimate the background of
false positive to be 8 + 8 ¼ 16 tags out of 533 + 266
¼ 799, or  2%.
Vector insertion profile
Lentiviral vectors are known to integrate preferentially into
transcribed regions of the genome (5). As a further validation
of our method, we checked whether a similar bias was
observed in the ISF library and in the tag populations. Addi-
tional HeLa ISF library clones (n ¼ 932) were sequenced
and 607 insertion sites could be identiﬁed. As expected, the
number of insertion sites found on each chromosome was
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Figure 2. Redundancy of sequenced tags in a typical VITA experiment.
VITA was performed onto a HeLa cell population transduced with a lentiviral
vector.2480 21 or 22 bp long tags were generated and counted. Boxes
represent the number of tags sequenced once, twice, until more than 10 times.
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Figure 3. Evolution of the number of sequenced tags in function of
cumulated number of sequenced nucleotides. The 2480 tags generated by
running VITA on a HeLa cells were mapped on the human genome and
classified in different categories. Curves represent ‘total different tags’
(diamond), ‘unique hits’ (square), ‘no hits’ (triangle) and ‘multiple hits’
(cross) (see Discussion).
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rate ¼ 0.79, P-value ¼ 2.072e 6). The same correlation
was observed with the 1349 ‘one-hit’ tags described
in HeLa tag library (Pearson’s correlation rate ¼ 0.86,
P-value ¼ 2.84e 8). These results suggest that the tag
population properly reﬂects the actual integrome (Figure 4).
DISCUSSION
LAM-PCR is the reference method for analyzing retroviral
integration sites. In this method, a library of ‘insertions
site fragments’ is cloned and sequenced. Each clone gives
information about one insertion site. Clone sequencing is
the limiting step of this technique. In order to accelerate the
discovery of insertion sites, we propose a new method called
VITA based on LAM-PCR with a supplementary step to
obtain genomic tags of each clones. Tags are obtained and
concatenated as in the ‘long-SAGE’ method of transcriptome
analysis (12) resulting in a 20–25-fold increase of data
output.
The ﬁrst part of VITA is similar to the LAM-PCR protocol
published by Schmidt et al. (10) with some differences: the
ﬁrst step in LAM-PCR is a 100 cycles of linear ampliﬁcation
followed by a double strand synthesis with random oligonu-
cleotides and anchoring enzyme digestion. Compatible
adaptors are then added to perform a nested PCR of ISF
fragments. In our method the ﬁrst step is the anchoring
enzyme digestion, followed by compatible adaptor ligation
and six cycles of linear ampliﬁcation. During this step, the
adaptor strand which will be targeted by the nested PCR
is ampliﬁed together with the ISF fragment. No double
strand synthesis is included in our method. In our hands as
much as 90% of obtained clones have the expected structure
compared to 60% published by Burgess (8) who used
LM-PCR.
Genomic tags are extracted using the type IIS restriction
enzyme MmeI which cuts 20–22 nt apart its recognition
site. The length of the tags generated by the method (21 bp)
is a compromise between the informational content which
allows to unambiguously map them on the genome and the
capacity to concatenate a lot of them to be sequenced in a sin-
gle run. There are 54 586 284 predicted 21 nt long NlaIII tags
in the human genome reference sequence (hg 17, Interna-
tional Human Genome Sequencing Consortium), and 73%
of them are unique. If we consider that the integration pattern
is not correlated to the distribution of genomic NlaIII sites,
then 73% of identiﬁable tags generated by VITA should
point at unique genomic positions. Consistently, we obtain
68% ‘one hit’ tags when the predicted tags from 443 ISF
clones are searched against the human genome.
In contrast to ISF cloning and sequencing which localize
the exact point of vector integration site, VITA indicates
the coordinates of the NlaIII restriction fragment contain-
ing the vector insertion. The accuracy of VITA thus depends
on the average length of NlaIII genomic fragments. An
in silico NlaIII restriction analysis of the human genome
indicates that in 85% of cases, VITA will have preciseness
better than 400 nt and in 99% of cases better than 1200 nt
(Figure 5). Since the actual junction sequences are not
determined by the method, it is critical to make sure that
the proportion of ‘false tags’ which map on the genome but
do not correspond to real insertion sites is kept minimal.
For this reason it is paramount to perform a careful quality
control of the ISF library. Using the protocol described
here, we routinely obtain >90% of ISF clones that contain
true insertions. The other would not contribute to the tag
population because they lack the MmeI site or do not
match the genome. In addition, tag population show the
same bias for gene rich regions as the ISF population,
suggesting that tag libraries properly reﬂect the composition
of ISF libraries.
In this study we used NlaIII as anchoring enzyme with the
HIV1-SIN vector. VITA oligonucleotides can be adapted to
other restriction enzymes or vectors, with the following
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to avoid a vector internal ampliﬁcation fragment. (ii) the
anchoring enzyme should not cut between bOC and the end
of the vector. A few base recognition site is better because
ISFs will be shorter and the nested PCR less biased. NspI
which generates compatible ends with NlaIII can be alterna-
tively used without any change in OL adaptor oligonu-
cleotides (data not shown).
As a PCR-based technique, VITA can present ampliﬁca-
tion biases. We tried to minimize this problem by choosing
a frequently cutting anchoring enzyme to reduce the length
of ISF fragments. The tag recovery step uses nested PCR
over a constant length tag population with common primers
and should not introduce important ampliﬁcation biases.
SAGE, which features a similar step is considered a ‘quanti-
tative’ method. In conclusion, VITA biases should not be
more pronounced than in LM or LAM-PCR.
VITA can be further improved. The LN adaptor introduces
a TT dinucleotide in the tags for orientation purpose, but tags
starting with AA cannot be properly oriented. The proportion
of ‘unorientable’ tags can be strongly reduced by adding two
additional nucleotides. We have used a TTTT sequence in
LN which generates 25 nt tags (instead of 23) without loss
of efﬁciency (data not shown). Alternatively, more speciﬁc
anchoring enzyme (5 or 6 nt recognition site) can be used
with a more processive DNA polymerase to compensate the
increment of ISF size. This should allow adapting VITA to
other vectors carrying NlaIII site between bOC and the
end of the LTR. Other commercially available polymerases
with editing activity could also be used to decrease the
‘mutated tag’ rate.
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